Entacapone clinical trials
Also written Comtan and Comtess.
How each study uses entacapone is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the entacapone studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 19 Oct 1999 · COMTAN · NDA 020796 (FDA, Drugs@FDA)
- European Union
- 16 Sept 1998 · Comtess · EMEA/H/C/000170 (EMA)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
21 studies that test it; most in 2005 (3)
| Year | Studies |
|---|---|
| 1997 | 1 |
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 2 |
| 2005 | 3 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 3 |
| 2010 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2020 | 1 |
| 2023 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 10 · Other 11
Novartis (5) · Novartis Pharmaceuticals (3) · Orion Corporation, Orion Pharma (2) · Satish R. Raj (1) · Xiangya Hospital of Central South University (1) · Oregon Health and Science University (1) · New York State Psychiatric Institute (1) · Rambam Health Care Campus (1)
Often tested with
Tested in the same studies.
Carbidopa (13) · Levodopa (12) · Acetazolamide (1) · Atomoxetine (1) · Clonidine (1) · Propranolol (1) · Indomethacin (1) · Mecamylamine (1)
Studies
Open first, then newest update. How each study uses entacapone is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 21
- Entacapone Plus Bevacizumab for Glioblastoma at First RecurrenceNot yet recruitingPhase 1/2First Affiliated Hospital of Wenzhou Medical UniversityNCT07831187Written as Entacapone
- Basic and Clinical Studies of Levodopa/Carbidopa/Entacapone in the Treatment of Early Parkinson's DiseaseRecruitingPhase 4Second Affiliated Hospital of Soochow UniversityNCT06236230Written as levodopa/carbidopa/entacapone
- Treatment of Orthostatic IntoleranceActive, not recruitingPhase 1/2Satish R. RajNCT00262470Written as Entacapone
- An Extension Study of Entacapone in Patients With Parkinson's Disease With End-of-dose Wearing-off. This Study is Not Recruiting in the United StatesCompletedPhase 2NovartisNCT00237263Written as Entacapone
- Entacapone Combination With Imatinib for Treatment of GISTCompletedEarly Phase 1Xiangya Hospital of Central South UniversityNCT04006769Written as Entacapone
- Pilot Study of Entacapone for Methamphetamine AbuseCompletedEarly Phase 1Oregon Health and Science UniversityNCT02058966Written as Entacapone
- Behavioral and Physiological Effects of Cocaine in Cocaine-dependent Participants Treated With Levodopa in Combination With Carbidopa and Entacapone (LCE)CompletedPhase 1New York State Psychiatric InstituteNCT01437293Written as L-dopa / carbidopa / entacapone (LCE)
- A Study to Evaluate Fixed Dose Carbidopa/Levodopa/Entacapone Versus Immediate Release Carbidopa/LevodopaCompletedPhase 3NovartisNCT00134966Written as capsules containing: carbidopa (25 mg), levodopa (100 mg), entacapone (200 mg)
- Effects of Carbidopa/Levodopa/Entacapone on Motor Function and Quality of Life in Patients With Parkinson's DiseaseCompletedPhase 4Novartis PharmaceuticalsNCT00219284Written as Carbidopa/levodopa/entacapone
- Study to Compare the Effect of Treatment With Carbidopa/Levodopa/Entacapone on the Quality of Life of Patients With Parkinson's Disease. This Study is Not Recruiting in the United StatesCompletedPhase 4NovartisNCT00143026Written as carbidopa, levodopa, entacapone
- Effect of Entacapone on Bodyweight Loss in Obese PopulationStatus unknownPhase 1/2Kaichun WuNCT02349243Written as Entacapone
- Augmenting Effects of L-DOPS With Carbidopa and EntacaponeTerminatedPhase 1/2National Institute of Neurological Disorders and Stroke (NINDS)NCT00547911Written as Entacapone
- Carbidopa/Levodopa Versus Carbidopa/Levodopa/Entacapone on Markers of Event Related Potentials (ERPs) in Patients With Idiopathic Parkinson's Disease (PD) and End-of-dose Wearing OffWithdrawnPhase 4Novartis PharmaceuticalsNCT00601978Written as Carbidopa/Levodopa/Entacapone
- Efficacy and Safety of Carbidopa/Levodopa/Entacapone in Patients With Parkinson's Disease Requiring Initiation of Levodopa TherapyCompletedPhase 3Novartis PharmaceuticalsNCT00099268Written as Carbidopa/levodopa/entacapone
- Efficacy of Levodopa/Carbidopa/Entacapone vs Levodopa/Carbidopa in Parkinson's Disease Patients With Early Wearing-offCompletedPhase 4NovartisNCT00391898Written as Levodopa/carbidopa/entacapone
- Carbidopa/Levodopa/Entacapone Versus Immediate Release (IR) Carbidopa/Levodopa on Non-motor Symptoms in Patients With Idiopathic Parkinson's Disease and Demonstrating Non-motor Symptoms of Wearing OffTerminatedPhase 4NovartisNCT00642356Written as Carbidopa/levodopa/entacapone
- Entacapone Augmentation for SchizophreniaCompletedNot applicableRambam Health Care CampusNCT00192855Written as Entacapone
- Pharmacokinetics of Levodopa/Carbidopa Infusion With and Without Oral Catechol-O-methyl Transferase (COMT) InhibitorsCompletedPhase 4Uppsala UniversityNCT00906828Written as entacapone
- Pharmacokinetic Study With Repeated Doses of StalevoCompletedPhase 1Orion Corporation, Orion PharmaNCT00693862Written as levodopa, carbidopa, entacapone
- An Open-Label Feasibility/Pilot Study With [123I]-IBZM SPECT (DOPA-SYN)CompletedPhase 2Molecular NeuroImagingNCT00200447Written as carbidopa/l-dopa/entacapone
See all 21 studies that test entacapone →
Given beside what is tested · 9 — entacapone is usual care or a partner of the new treatment
- [18F]F-DOPA Imaging in Patients With Autonomic FailureRecruitingPhase 1Daniel ClaassenNCT04246437Written as Entacapone 400mg oral dose
- A Safety, Tolerability and Levodopa Pharmacokinetics Study of Repeated ND0612 in Parkinson's Disease PatientsCompletedPhase 2NeuroDerm Ltd.NCT01883505Written as Entacapone
- A Safety, Tolerability, and Pharmacokinetic Study of ND0612 Delivered as a Continuous Subcutaneous in Parkinson's Disease PatientsCompletedPhase 1NeuroDerm Ltd.NCT02096601Written as Entacapone
- A Study to Compare IPX066 and Carbidopa/Levodopa/Entacapone (CLE) Followed by an Open-Label Safety Study of IPX066CompletedPhase 3Impax Laboratories, LLCNCT01130493Written as CLE
- Effect of BIA 6-512 at Steady-state on the Levodopa PharmacokineticsCompletedPhase 1Bial - Portela C S.A.NCT03094156Written as Comtan®
- Pharmacokinetics of Rising Single-doses of BIA 6-512 and Their Effect on the Levodopa PharmacokineticsCompletedPhase 1Bial - Portela C S.A.NCT03091868Written as Comtan®
- The Effect of BIA 9-1067 at Steady-state on the Levodopa PharmacokineticsCompletedPhase 1Bial - Portela C S.A.NCT02170376Written as Entacapone
- Study of BIA 9-1067 to Investigate Its Effect on Levodopa PharmacokineticCompletedPhase 1Bial - Portela C S.A.NCT01519284Written as Entacapone
- PET-Study: Effects of Single Doses of Stalevo and Levodopa/Carbidopa on Striatal 11C-Raclopride BindingTerminatedPhase 2Orion Corporation, Orion PharmaNCT00562198Written as entacapone and carbidopa
As the comparator · 8 — what is tested is compared with entacapone
- Efficacy and Tolerability of Nebicapone in Parkinson's Disease Patients With "Wearingoff" PhenomenonCompletedPhase 2Bial - Portela C S.A.NCT03103399Written as Comtan®
- Effect of Two Multiple-dose Regimens of BIA 3-202 on the Pharmacokinetics and Motor Response of Levodopa, and on the Erythrocyte Comt Activity in Parkinson's Disease PatientsCompletedPhase 2Bial - Portela C S.A.NCT02834507Written as Comtan®
- Pharmacokinetic Study in Healthy VolunteersCompletedPhase 1Orion Corporation, Orion PharmaNCT02554734Written as levodopa, carbidopa, entacapone
- Efficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients With "Wearing-off" PhenomenonCompletedPhase 3Bial - Portela C S.A.NCT01568073Written as Entacapone
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ODM-104 in Healthy VolunteersCompletedPhase 1Orion Corporation, Orion PharmaNCT01840423Written as Entacapone
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ODM-103 in Healthy VolunteersCompletedPhase 1Orion Corporation, Orion PharmaNCT01688089Written as Entacapone
- PK, PD and Safety of Multiple Doses of V1512 Tablets in PD Patients Compared to Standard Levodopa/Carbidopa Oral TabletsCompletedPhase 1/2Vernalis (R&D) LtdNCT00491998Written as V1512 and Entacapone
- COMT Polymorphism and Entacapone EfficacyCompletedPhase 4Assistance Publique - Hôpitaux de ParisNCT00373087Written as entacapone
Codes
What other systems call entacapone · ClinicalTrials.gg INT003592
- MeSH (NLM) C071192entacaponeConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 4975G9NM6TENTACAPONEConfirmed FDA, NLM, Wikidata
- RxNorm 60307Confirmed FDA, Wikidata
- Wikidata Q416444entacaponeConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C61746EntacaponeOne source FDA
- DrugBank DB00494One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C071192 | entacapone | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 4975G9NM6T | ENTACAPONE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 60307 | — | Confirmed FDA, Wikidata |
| Wikidata | Q416444 | entacapone | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C61746 | Entacapone | One source FDA |
| DrugBank | DB00494 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.